Neuroprotection in Glaucoma: NAD(+)/NADH Redox State as a Potential Biomarker and Therapeutic Target

Glaucoma is the leading cause of irreversible blindness worldwide. Its prevalence and incidence increase exponentially with age and the level of intraocular pressure (IOP). IOP reduction is currently the only therapeutic modality shown to slow glaucoma progression. However, patients still lose visio...

Descripción completa

Detalles Bibliográficos
Autores principales: Petriti, Bledi, Williams, Pete A., Lascaratos, Gerassimos, Chau, Kai-Yin, Garway-Heath, David F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226607/
https://www.ncbi.nlm.nih.gov/pubmed/34198948
http://dx.doi.org/10.3390/cells10061402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226607/
https://www.ncbi.nlm.nih.gov/pubmed/34198948
http://dx.doi.org/10.3390/cells10061402

Ejemplares similares